Predictors of sexual function in women after treatment for breast cancer.

Kowalczyk, Robert; Cedrych, Ida; Lew-Starowicz, Zbigniew; Nowosielski, Krzysztof; Krzemieniecki, Krzysztof; Krzystanek, Marek; Głogowska, Iwona; Streb, Joanna; Kucharz, Jakub

doi:10.1200/jco.2016.34.15_suppl.10071

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The type of treatment received such as radiation therapy and surgery have also been identified as predictors of reduced sexual activity in women (Traa et al, 2012 ). Kowalczyk et al ( 2016 ) found that the main three predictors of sexual dysfunction among women were the lack of sexual partner, lower levels of support from the partner and higher levels of anxiety.…”

Section: Introductionmentioning

confidence: 99%

Sexual activity and cancer: A systematic review of prevalence, predictors and information needs among female Arab cancer survivors

Alananzeh

Green²,

Meedya

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Introduction:The objective of this review is to synthesise and present the best available evidence on the prevalence, predictors and information needs about sexual health among female Arab cancer survivors. Methods:The databases searched included MEDLINE, Embase and CINAHL from inception of the database until March 2020. The review was undertaken according to the JBI guidelines. Proportional meta-analysis using a random effects model was used for statistical pooling through JBI SUMARI.Results: Seven studies involving female Arab cancer survivors were included in the review. The overall prevalence of sexual dysfunction ranged from 16.7 to 67% (pooled estimate 51%, 95% CIs 21.7% to 80.2%). Dyspareunia and erectile dysfunction were the two main types of sexual dysfunction reported after diagnosis, and the overall prevalence ranged from 42.5% to 65% and 38% to 61%, respectively. The prevalence of vaginal dryness was ranged from 19.8% to 54.2%, and dyspareunia ranged from 22.2% to 65%. The lack of sexuality information and communication with health care providers (HCPs) was also reported in the included studies. Conclusion:Cancer and its treatment may result in significant difficulties with sexual activity and sexual functioning among cancer survivor. Communication between the health care professionals and cancer survivors is essential to overcome this problem and improve the quality of life of female Arab cancer survivors.

show abstract

Section: Introductionmentioning

confidence: 99%

Sexual activity and cancer: A systematic review of prevalence, predictors and information needs among female Arab cancer survivors

Alananzeh

Green²,

Meedya

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

show abstract

“…The effects of chemotherapy and radiotherapy commonly used to treat cancers do not only affect hormone levels, which may induce early menopause; other side effects such as alopecia and nausea are also signi cant contributory factors, which can lead to reduced interest in sexual activities (8,9). In addition, the indirect effect, such as concomitant psychological stress associated with cancer diagnosis, has been demonstrated to be associated with worse sexual function (10,11).…”

mentioning

confidence: 99%

Sexual Dysfunction and Its Impact on Quality of Life among Female Haematological Cancer Patients: A Cross- Sectional Study in Malaysia

Gan,

Ng,

Kerishnan

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: Sexual function (SD) and quality of life (QoL) are significantly impacted by cancer and its treatments. However, information on sexual function is scarce, particularly among female patients with underlying haematological malignancies in Asia. This study aims to determine the prevalence of SD in these patients, identify associated factors, and examine their effects on QoL. Methods: This cross-sectional study, conducted in Malaysia from 2014–2016, involved female patients with haematological malignancies who were on active treatment or had completed active treatment. Sociodemographic and clinical data were obtained through patients interviews and medical records. Sexual functions were assessed using the Female Sexual Function Index, psychological aspects with the Hospital Anxiety and Depression Scale (HADS), and health-related QoL using the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 version 3.0 questionnaire. Data were analysed using SPSS software. Results: Of the 89 patients recruited, 82% reported SD. Significant associations were found between SD and menopause (OR, 5.7; 95% CI, 1.60-20.34; p = 0.007) and higher HADS-depression score (OR, 1.6; 95% CI, 1.14–2.21; p = 0.006). Patients with SD exhibited lower median scores in Global Health Status/ QoL (QL2) (66.7 [IQR 33.3] vs. 91.7 [IQR 33.3], p = 0.009), role function (83.3 [IQR 33.3] vs. 100 [IQR 16.7], p = 0.033), cognitive function (83.3 [IQR 25.0] vs. 100 [IQR 16.7]) and pain (33.3 [IQR 33.3] vs. 0 [IQR 16.7]). Weak positive correlations were observed between FSFI score and QL2 (Rs = 0.252, p = 0.018), and cognitive function (Rs = 0.237, p = 0.026), while a moderate positive correlation was found with role function (Rs = 0.315, p = 0.003). Conclusions: SD is highly prevalent in female patients with haematological cancers, significantly impacting QoL, and this needs to be addressed accordingly.

show abstract

Predictors of sexual function in women after treatment for breast cancer.

Cited by 2 publications

References 0 publications

Sexual activity and cancer: A systematic review of prevalence, predictors and information needs among female Arab cancer survivors

Sexual activity and cancer: A systematic review of prevalence, predictors and information needs among female Arab cancer survivors

Sexual Dysfunction and Its Impact on Quality of Life among Female Haematological Cancer Patients: A Cross- Sectional Study in Malaysia

Contact Info

Product

Resources

About